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Abstract The International Headache Society (IHS)
defines ophthalmoplegic migraine (OM) as recurrent
attacks of headache with migrainous characteristics, asso-
ciated with paresis of one or more ocular cranial nerves
(commonly the third cranial nerve), and in the absence of
any demonstrable intracranial lesion other than MRI chan-
ges within the affected nerve. According to the IHS criteria,
it is diagnosed when at least two attacks with migraine-like
headaches are accompanied with, or followed within 4 days
of onset by, paresis of one or more of the third, fourth or
sixth cranial nerves. Parasellar, orbital fissure and posterior
fossa lesions should be ruled out by appropriate investiga-
tions. It is unlikely that OM is a variant of migraine, since
the headache often lasts for a week or more and there is a
latent period of up to 4 days from the onset of headache to
the onset of ophthalmoplegia. Furthermore, in some cases
MRI shows gadolinium uptake in the cisternal part of the
affected cranial nerve and this suggests that the condition
may be a recurrent demyelinating neuropathy. In general,
patients demonstrated a: (1) prolonged time for symptom
resolution to occur (median time 3 weeks); (2) tendency for
recurrent episodes to have more severe and persistent nerve
involvement; (3) evidence of permanent neurological
sequelae with recurrent episodes (30% of patients); (4)
rapid improvement and shortened duration with cortico-
steroid therapy and; (5) transient, reversible MRI contrast
enhancement of the affected cranial nerve (86% of
patients). Different pathogenetic mechanisms, which
include compressive, ischemic and inflammatory, have
been suggested for OM. Here, a 15-year-old Ethiopian with
recurrent attacks of headache and third nerve palsy is pre-
sented. The subsequent discussion focuses on current
evidences with regard to the clinical characteristics, possi-
ble pathogenetic mechanisms and treatment. Finally, a brief
discussion of the situation in Africa will be presented.
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Presentation of the case
The patient is a 15-year-old male who had recurrent attacks
of headache for the past 10 years. The pain is left hemi-
cranial, more retro-orbital, throbbing/aching and moderate
to severe in intensity. It is associated with photophobia and
phonophobia, but not with nausea and vomiting. After the
initial attack, he has similar episodes coming every year.
Each attack is followed after 2 or 3 days by the drooping of
the eyelid on the left side and with difficulty moving the
eyes sideways, and diplopia. The weakness lasts for about
2–3 months and gradually resolves and recovery is com-
plete. He has no associated weakness of the extremities or
the face, numbness, abnormal body movements, protrusion
of the eye on the affected side or pain on moving the eyes.
He has a family history of recurrent headaches: his mother
and his paternal grandmother have migraine-like headache,
but no abnormality around the eyes. He is the fourth child
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in the family and has five brothers and two sisters, and all
are healthy.
When examined during the last attack, four days after
the onset of headache, the headache had resolved and the
patient was not in any form of pain. His left pupil was
4 mm and his right 2 mm. His extra-ocular movements
were consistent with a complete III nerve palsy with dilated
and sluggishly reactive pupil. Fundoscopic examination
was unremarkable and there was no exophthalmos. The
other cranial nerves including the 4th and the 6th were
normal. There was no abnormality on motor and sensory
examination. Gait and stance were normal. Laboratory
evaluation: normal complete blood count and erythrocyte
sedimentation rate, the renal and liver function tests were
normal, and his blood sugar was normal. Magnetic reso-
nance imaging without contrast administration revealed no
mass lesions. Examination 2 months after the onset of the
headache showed complete recovery of extra-ocular motor
function and there was mild pupillary dilatation.
Discussion
The international classification of headache disorders
classifies ophthalmoplegic migraine (OM) under ‘cranial
neuralgias and central causes of facial pains’ and not
under migraine. It does not consider this condition as
migraine, but rather as neuralgia [1]. The International
Headache Society (IHS) defines OM as recurrent attacks
of headache with migrainous characteristics, associated
with paresis of one or more ocular cranial nerves (com-
monly the third cranial nerve) and in the absence of any
demonstrable intracranial lesion other than MRI changes
within the affected nerve. According to the IHS criteria, it
is diagnosed when at least two attacks with migraine-like
headaches are accompanied with, or followed within
4 days of onset by, paresis of one or more of the third,
fourth or sixth cranial nerves. Parasellar, orbital fissure
and posterior fossa lesions should be ruled out by
appropriate investigations. Headache is described as
migraine like in the ICHD-II, but in most published cases
the description is non-existent or poor [2]. But, in the
cases of Giraud et al. [2], the description of the pain does
not appear different in type, location or intensity from the
usual migraine attacks. According to Crevits [3], the type
of headache with which occasional episodes of OM are
associated varies from case to case and no characteristic
headache type has been identified. Accordingly, the above
mentioned patient who fulfills all the criteria for the
diagnosis of OM (recurrent attacks of migraine like
headache, followed in 2–3 days by the third cranial nerve
lesion, and absence of other lesions explaining the
abnormality on MRI taken without contrast).
Historically, the first case of OM was attributed to Gu-
bler in 1860. The first English language case by Saundby in
1892 described a 19-year-old female with repeated epi-
sodes of headache and third nerve palsy. Charcot used the
term ‘‘migraine ophtalmoplegique’’ in 1890 and referred to
19 previously published cases [4].
It is a very rare condition. The prevalence is estimated to
be 0.7 per million [5–7]. Hansen et al. [5] reviewed the charts
of patients admitted from April 1976 to March 1986 to the
departments of neurology, neurosurgery, ophthalmology and
pediatrics, serving a population of 615,000 inhabitants in
Copenhagen County. They then examined patients with
coexisting headache and ophthalmoplegia at follow-up.
Many diseases may mimic a single attack of OM. They found
four cases of OM, i.e., an annual incidence of 0.7 per million
inhabitants. In another series of 5,000 cases of migraine
headache, only 8 had this uncommon form of headache [8,
9]. In his review on OM, Daroff [4] also noted the rarity of the
condition and stated that in the late 1970s he estimated the
number of cases with OM to be 1–2 cases per year and he did
not see a case in the 14 years before 1994. In a more recent
review, Giraud et al. in a retrospective and multicentre
database analyzed only nine cases considered as having
headaches with oculomotor palsy from among 52,973 cases.
According to Carlow [1], over a 7-year period, he examined
six children who fulfilled the clinical criteria for ophthal-
moplegic migraine. The exception was that all children had
abnormal MRI scans at the oculomotor midbrain exit, sug-
gesting a focal pathologic process. In his series, five of six
patients were girls. The age of onset varied from 16 months
to 9 years, with a mean of 3.7 years. Headache preceded the
onset of a third nerve paralysis by up to 11 days. The pupil
was dilated in five. Each child had at least 2 and as many as 12
events. Permanent oculomotor paresis or paralysis was
present in four of the six children after multiple episodes, and
two developed aberrant regeneration. Four of the six children
had headaches unassociated with oculomotor paresis [10]. In
general, unlike patients with migraine, patients with OM
demonstrated: (1) prolonged time for symptom resolution to
occur (median time 3 weeks); (2) tendency for recurrent
episodes to have more severe and persistent nerve involve-
ment; (3) evidence of permanent neurological sequelae with
recurrent episodes (30% of patients); (4) rapid improvement
and shortened duration with corticosteroid therapy and; (5)
transient, reversible MRI contrast enhancement of the
affected cranial nerve (86% of patients) [11].
It is unlikely that OM is a variant of migraine, since the
headache often lasts for a week or more and there is a latent
period of up to 4 days from the onset of headache to the onset
of ophthalmoplegia [1???]. Furthermore, in some cases MRI
shows gadolinium uptake in the cisternal part of the affected
cranial nerve and this suggests that the condition may be a
recurrent demyelinating neuropathy. Mark et al. [12]
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reported six cases with typical features of OM in whom
enhancement of the cisternal segment of the oculomotor
nerve developed during the acute phase followed by reso-
lution of enhancement over several weeks as the symptoms
resolved. They concluded that an intrinsic transient abnor-
mality in the cisternal segment of the third nerve had a
pathophysiologic mechanism in patients with a typical
clinical presentation of ophthalmoplegic migraine. In
another study, O’Hara et al. reported on two children with
ophthalmoplegic migraine and characteristic magnetic res-
onance imaging (MRI) findings post enhancement with
gadopentetate dimeglumine diethylenetriamine pentaacetic
acid (Gd-DTPA). In both cases, enhancement and thickening
of the cisternal segment of the oculomotor nerve were
present at initial presentation. Ophthalmoplegia resolved
spontaneously in one child and after steroid treatment in the
other. Both post resolution MRIs demonstrated decrease in
enhancement and thickening of the third nerve. They stated
that the enhancing, thickened lesion identified on MRI in
these patients may represent an inflammatory process similar
to Tolosa-Hunt syndrome occurring in the interpeduncular
segment of the oculomotor nerve. MRI of the brain post
enhancement is a useful adjunct in the diagnosis and treat-
ment of ophthalmoplegic migraine and should be considered
as part of a workup of OM in children [13].
Although the oculomotor is the commonly involved
nerve in OM, there are case reports for the involvement of
the 4th and 6th cranial nerves. Abducens nerve involve-
ment is said to occur in about 10% of patients with OM
[14]. Lee et al. [15] described a patient with OM and right
abducens palsy, who had reversible enhancement of the
intraparenchymal part of the nerve with MRI during both
the headache and headache-free periods. They also showed
with thin MRI sections that gadolinium enhancement of the
posterior brainstem area corresponds to the intraparen-
chymal pathway of the abducens nerve. This area is also
the location of the raphe nuclei, which regulate serotonin
production, a crucial neurotransmitter in migraine. Verha-
gen et al. [16] described a patient from The Netherlands,
who had onset in middle age of features of OM with
abducens palsy. Vasconcelos [17] also reported on a 40-
year-old female patient from Brazil with OM and recurrent
abducens palsy. Van der Dussen et al. [18] reported a case
of recurrent ophthalmoplegic migraine with oculomotor
and trochlear palsies and reversible MRI enhancement and
thickening of the trochlear nerve.
Possible pathogenesis of ophthalmoplegic migraine
A number of theories have been suggested for the mechanism
of ophthalmoplegic migraine [19]. Stommel et al. [19] sug-
gested an ischemic mechanism of ophthalmoplegic
migraine, given the MRI findings of enhancement of the third
cranial nerve at the point of exit from the brainstem. How-
ever, the third cranial nerve did not enhance on MRI imaging
in patients with diabetic oculomotor palsy, even though this
condition is thought to be due to ischemia [20]. Shin et al.
also suggested a possible ischemic mechanism for OM. They
evaluated two patients with OM with electroencephalogra-
phy, brain MRI, angiography and SPECT during an attack.
Follow-up SPECT was also performed after the neurologic
symptoms resolved. In both patients, SPECT during an
attack of ophthalmoplegia and headache demonstrated sig-
nificantly decreased regional cerebral blood flow in the
thalamus on the side of the ophthalmoplegia, which reverted
to normal on the follow-up examination during symptom-
free periods. They concluded that reversible ischemia in the
territories of the perforating branches of the posterior cere-
bral artery may accompany OM and possibly bear some
relationship to the clinical features [21]. An ischemic
mechanism has also been proposed secondary to reduced
blood flow in the appropriate circulation to ocular motor
nerves. In fact, about two-thirds of patients with ophthal-
moplegic migraine involving the oculomotor nerve have at
least partial pupillary sparing [9, 22]. Vijayan [22] reported
on a patient with OM and oculomotor palsy with pupillary
sparing and suggested a possible ischemic mechanism. They
stated that most of the clinical evidence suggests that the
ophthalmoplegia of OM is due to a delayed ischemic neu-
ropathy. This results from swelling of the walls of the carotid
and/or basilar arteries leading to occlusion of the ostia of the
smaller vessels, which supply the involved cranial nerves.
The course and evolution of ophthalmoplegia suggest that
this ischemia leads to a border zone infarction of the nerves.
This is very similar to the ischemic neuropathy associated
with diabetes. Nevertheless, pupillary sparing does some-
times occur with compressive lesions of the oculomotor
nerve such as aneurysms in the cavernous sinus. Penetration
of the oculomotor nerve by the circumflex mesencephalic
artery or by a branch of the perforating vessels of the pos-
terior cerebral artery occurs frequently [23]. Vasospasm or
dilatation of these vessels during migraine attacks could
infarct the perimesencephalic portion of the oculomotor
nerve. The long circumflex mesencephalic artery supplies
the dorsolateral midbrain, crus cerebri, substantia nigra, red
nucleus, medial lemniscus, spinothalamic tract, reticular
formation, superior colliculi and portions of the pretectal and
diencephalic regions; thus ischemia in the distribution of
such a vessel could result in hemiparesis, supranuclear facial
and genioglossus paresis, extrapyramidal disturbances and
ataxia in addition to ophthalmoplegia[19].
The compressive theory for ophthalmoplegic migraine
suggests that one or more of the ocular motor nerves is
compressed by an edematous or dilated intracavernous
portion of the carotid artery. Walsh and O’Doherty [24]
J Headache Pain (2009) 10:45–49 47
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suggested that cavernous carotid artery enlargement occur-
red with the compression of the intracavernous cranial
nerves. Vieira et al. [25] reported on a 7-year-old boy with
typical symptoms of OM, whose angiography (both mag-
netic resonance and computerized tomography angiography)
revealed the presence of an infundibular dilatation of a per-
forating branch of the posterior cerebral artery adjacent to the
symptomatic third cranial nerve. They speculated that the
contact between the third nerve and the dilated intracranial
artery could episodically produce a migrainous syndrome
sustained by activation of the trigeminovascular system as
well as compression and paralysis of the third nerve. Others
proposed an infectious or inflammatory pathogenesis for
ophthalmoplegic migraine [11, 26, 27]. Lance and Zagami
[28] consider the possibility that ophthalmoplegic migraine
is a recurrent neuritis or demyelinating neuropathy. An
inflammatory process could trigger migraine headaches in
people who are already migraineurs. Discussing the findings
of four cases with OM, Lance and Zagami noted that the MRI
appearances of the enhancement of the oculomotor nerve, as
it emerges from the midbrain, favors demyelination or
inflammation of the oculomotor nerve in cases of ‘‘oph-
thalmoplegic migraine’’, rather than an ischemic lesion. The
most striking feature of the usual MRI changes is the globoid
appearance of the first part of the oculomotor nerve on
emerging from the midbrain, indicating a gross localized
enlargement of the nerve, consistent with intraneural edema
as reported in some experimental demyelinating neuropathy
and in chronic inflammatory demyelinating polyneuropathy
(CIDP) [28].
Differential diagnosis of ophthalmoplegic migraine
A number of other conditions that are similar to ophthal-
moplegic migraine can present; hence, exclusion of
vascular, neoplastic, infectious and inflammatory causes
must be the first step in the workup of these patients [14].
These include aneurysm (generally of the posterior com-
municating artery), tumor or abscess in the region of the
cavernous sinus or superior orbital fissure, Tolosa-Hunt
syndrome, sphenoid sinus pathology, diabetic cranial nerve
3, 6 or 4 dysfunction, nerve sheath tumor of cranial nerves 3,
6 or 4, and meningitis or other inflammatory processes such
as Lyme disease, sarcoidosis, fungal infection and tubercu-
losis. Cavernous sinus syndrome is suggested by upper facial
(and corneal) hypesthesia and Horner’s syndrome [14].
Treatment
The rarity of OM has made a comprehensive study of
treatment difficult. Prophylactic treatment seems warranted
to prevent the development of permanent ocular palsies
seen in OD. Calcium channel blocker or b-blocker medi-
cation is appropriate if the pathophysiology is akin to
migraine. Some authors have recommended standard
migraine prophylactic therapy with b-blocker or calcium
channel blocker medication for patients with recurrent
attacks [14]. Although there are no controlled studies on
the effect of steroids, some authors conclude that prompt
administration of steroids at the time of attack might
minimize permanent sequelae of OM, including residual
weakness of the third cranial nerve and pupillary dys-
function [29].
Ophthalmoplegic migraine from African studies
Like studies done in other parts of the world, African
studies have shown a very small incidence of OM. Okogbo
[30] evaluated 51 patients to determine the profile of
migraine in Nigerian children and commented that com-
plicated migraine phenomenon such as hemiplegia or
ophthalmoplegia were not observed, although migraine
complicated by a hemiplegic or hemisensory aura is
thought to be commoner in children than in adults. It is
possible that some of the cases of unexplained hemiplegia
in their clinic may be of migrainous origin. A long-term
follow-up may help resolve this.
In a study to determine the causes of severe headache
in Sierra-Leone, Lisk [31] evaluated 250 indigenous
Sierra-Leoneans with different forms of headache and
found out that migraine was the most common cause of
severe headache and accounted for 40% of all cases.
There was only one case, which could either be oph-
thalmoplegic or hemiplegic (according to the 1962 ad hoc
committee classification of headache disorders, which
lumped hemiplegic and ophthalmoplegic migraine toge-
ther). This study also shows the rarity of OM in African
populations.
In Ethiopia, there are no case reports or other studies
on OM, and the prevalence or incidence of the condition
is not known. In his 1995 extensive study on the chronic
forms of headache in the rural community of Ethiopia,
Tekle-Haimanot [32] did not mention anything about the
occurrence of OM. It may be because those patients with
presumed OM were lumped under migraine with aura
category because OM was classified under migraine in
the first international classification of headache disorders
[33].
So, I believe that this case report would add to the
understanding of OM in our setup and open the door for
further community-based studies to look into the situation
in Africa and if there are any differences from those of
other countries.
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